FDA unveils game-changing revisions to Moderna vaccine
Shot can remain at room temperature for 24 hours; 15 doses can be extracted with upcoming new vial
Moderna revealed that based on submitted stability data, the FDA has authorized its Covid-19 vaccine to be kept at room temperature conditions once removed from the refrigerator for administration for up to 24 hours, an increase from the previous 12 hours. Further, a punctured vial is now useable for up to 12 hours, up from the previous six hours. These new guidelines are now reflected in an updated emergency use authorization (EUA) label.
FDA has also authorized a new vial with a maximum of 15 doses, which is expected to start shipping in the coming weeks. The agency also authorized a maximum of 11 doses of its vaccine in the current format, up from the previously authorized 10 doses per vial.
Moderna, with its two-dose jab, possesses one of three Covid vaccines authorized for emergency use in the US, alongside that of Pfizer-BioNTech (two doses) and Johnson & Johnson (one dose).
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
